Next, we analysed RPL36 mRNA levels by qRT‐PCR in the same 20 additional normal brain and 55 glioma tissue samples and found that RPL36 was up‐regulated in glioma tissues (Fig. 2A). The gene discussed is RPL36; the disease is central nervous system cancer.